MAGNITUDE Study

The MAGNITUDE Study is a Phase 3 randomized, placebocontrolled, doubleblind study comparing a combination of an investigational medicine and standard treatment, to a combination of a placebo and standard treatment for men with metastatic prostate cancer.

Learn More

https://clinicaltrials.gov/ct2/show/NCT03748641?term=NCT03748641&rank=1

Prostate cancer is a disease that is most successfully treated when it is detected early on.  As the research community explores various methods to detecting the disease, PCEC continues to encourage men to play an active role in their health by looking to those trusted sources of prostate cancer testing – the PSA and DRE.

Join Our Newsletter